Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsHybridoma isotypes, also known as antibody isotypes, are structures that are specific to Ig antigens and are present in all individuals of the same species. In mammals, there are five heavy chain isotypes: IgA, IgD, IgE, IgG, and IgM, each with their own focus and corresponding differences in serum content, ability to participate in immune functions, and ability to induce hypersensitivity reactions. Given their impact on immune functions, hybridoma isotype identification and switching are often necessary in experiments.
Hybridoma isoforms have different immune functions, so their identification is required according to specific experimental needs.
IgA antibodies play a crucial role in mucosal immunity, acting as the primary mediators of defense against infections in the respiratory or intestinal tract. While IgA is present in monomeric form in the bloodstream, it appears as dimers on the mucosal surface. The two subclasses of IgA differ in their hinge regions, with IgA1 being more sensitive to bacterial proteases and thus dominating serum IgA, while IgA2 is primarily found in mucosal secretions. Unlike other immunoglobulins, complement fixation is not a major effector mechanism for IgA at the mucosal surface. Neutrophils express IgA receptors and can be activated to mediate antibody-dependent cellular cytotoxicity.
IgD is a relatively understudied immunoglobulin, accounting for less than 1% of the total pool. It is typically found on the cell membrane of B cells, and its expression level correlates with B cell activation status. More research is needed to fully understand the role of IgD in serum.
IgE is typically found in basophils and mast cells and is associated with immediate type I hypersensitivity reactions. Its molecular weight is around 190 kDa, and it does not contain a hinge region but instead has two additional constant structural domains.
IgG is the most abundant antibody in serum and makes up 70-85% of the total immunoglobulin pool. It is typically present as a monomer and has a molecular weight of approximately 150 kDa. Four subclasses of IgG have been identified, each with differing structural characteristics and effector functions. IgG1 is the most abundant subclass and dominates the response to protein antigens, while IgG2 is mainly involved in the response to bacterial podoconjugate antigens and glycan antigens. IgG3 is a potent activator of the proinflammatory response and has the shortest half-life among the subclasses. IgG4 is the least abundant and is usually produced after repeated exposure to the same antigen or during persistent infection. Three subclasses of IgG (IgG1, IgG3, and IgG4) can cross the placental barrier and play a critical role in neonatal immunity against infection.
IgM is the first immunoglobulin expressed during B-cell development and is the primary antibody in the initial immune response. It has a molecular weight of approximately 900 kDa and can exist as monomers or pentamers. Its pentameric form allows for efficient binding to antigenic epitopes. Because IgM antibodies are expressed early in the B-cell response, they are typically not highly mutated and have broad antigen reactivity, providing an early response to a wide range of antigens without the need for T-cell help.
Isotype switching of antibodies involves changing the heavy chain type (constant region) while maintaining the same specificity for the bound antigen in the variable region. Factors such as antigen, immune route, immune adjuvant, Th cells, and cytokines can affect the outcome of isotype conversion during an immune response.
Hybridoma screening is an important step in ensuring the selection of the most productive and specific clones. At Creative Biolabs, we offer our expertise to help accurately identify and switch hybridoma isotypes to ensure the selection of the most productive and specific clones.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
